CUSIP: 03832V307
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,967,896
-
Share change
-
+1,964,969
-
Total reported value
-
$2,557,000
-
Price per share
-
$1.30
-
Number of holders
-
19
-
Value change
-
+$2,553,000
-
Number of buys
-
18
Quarterly Holders Quick Answers
What is CUSIP 03832V307?
CUSIP 03832V307 identifies APRI - APRICUS BIOSCIENCES INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03832V307:
Institutional Holders of APRICUS BIOSCIENCES INC - COM NEW (APRI) as of Q4 2016
As of 31 Dec 2016,
APRICUS BIOSCIENCES INC - COM NEW (APRI) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,967,896 shares.
The largest 10 holders included
Sarissa Capital Management LP, Anson Funds Management LP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, GEODE CAPITAL MANAGEMENT, LLC, Acrospire Investment Management LLC, A.R.T. Advisors, LLC, KCG HOLDINGS, INC., and Raymond James Financial Services Advisors, Inc..
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.